0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
AI In Genomics Market and the Expansion of Precision OncologyThe global AI in genomics market was valued at USD 1.3 billion in 2025 and is projected to reach USD 18.8 billion by 2033, expanding from USD 1.7 billion in 2026 at a 40.3% CAGR from 2026 to 2033. North America represented the leading regional market, accounting for 38.36% of global revenue in 2025. Market expansion is being driven by the rapid...0 Комментарии 0 Поделились 433 Просмотры 0 предпросмотр
-
Genomics Market Developments Around Personalized Cancer TreatmentThe global genomics market is entering a period of rapid expansion as genomic technologies become increasingly integrated into healthcare, pharmaceutical research, biotechnology, and other biological applications. The market was valued at USD 21.8 billion in 2025 and is expected to reach USD 22.6 billion in 2026. By 2033, the market is projected to reach USD 72.5 billion, representing a 18.2%...0 Комментарии 0 Поделились 119 Просмотры 0 предпросмотр
-
qPCR Instruments Market Future Scope and Business OpportunitiesThe global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Rare Disease Genetic Testing Market Industry Overview and Growth AnalysisThe global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр